Biostimulants Market Report 2026

The biostimulants market size has grown strongly in recent years. It will grow from $4.23 billion in 2025 to $4.59 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to declining soil fertility levels, increasing demand for higher crop productivity, growth of organic farming practices, rising awareness of sustainable agriculture inputs, availability of natural biostimulant formulations.

The biostimulants market size is expected to see strong growth in the next few years. It will grow to $6.43 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing adoption of climate-resilient farming, rising demand for residue-free crop inputs, expansion of precision farming technologies, growing investments in agricultural biotechnology, increasing focus on sustainable food production. Major trends in the forecast period include increasing adoption of biological crop enhancers, rising use of microbial and seaweed-based inputs, growing integration with precision agriculture, expansion of stress-resistance crop solutions, enhanced focus on sustainable yield improvement.

The increasing demand for organic food is anticipated to drive the growth of biostimulants going forward. Organic food refers to agricultural and food products produced through specific organic farming practices that prioritize environmentally sustainable and natural methods while minimizing synthetic chemicals. Biostimulants enhance plant growth, nutrient uptake, and stress tolerance to improve crop yield, quality, and sustainability in producing organic food for consumers. For instance, in May 2024, according to the Organic Trade Association (OTA), a US-based membership-based business association, total U.S. sales of certified organic products (food + non-food) reached about US$ 69.7 billion in 2023, marking a 3.4% increase over 2022. Therefore, the rising demand for organic food is driving the growth of the biostimulants market.

Major companies operating in the biostimulants market are innovating new products, such as the NeoVita 43, to provide reliable services to customers. NeoVita 43 is an agricultural biostimulant that boosts corn yields by improving nutrient use efficiency. For instance, in October 2023, The Archer-Daniels-Midland Company, a US-based food processing company launched NeoVita 43. NeoVita 43 biostimulant is applied with liquid starter fertilizer at planting and does not require additional mixing or special handling. This product improves nutrient availability, uptake or use efficiency, tolerance to abiotic stress, and consequent growth, development, quality, or yield.

In May 2025, ICL Group, an Israel-based provider of plant nutrition, specialty minerals, and agricultural solutions, acquired Lavie Bio for an undisclosed amount. Through this acquisition, ICL aims to accelerate its expansion into the global ag-biologicals market, strengthen its R&D and product development in microbial-based biostimulants and biopesticides, and advance its innovation pipeline for next-generation biological crop solutions. Lavie Bio is an Israel-based provider of microbiome-based agricultural biological solutions.

Major companies operating in the biostimulants market are BASF SE, Syngenta AG, Bayer AG, UPL Limited, FMC Corporation, Valagro S.p.A., Biolchim S.p.A., Isagro S.p.A., Italpollina S.p.A., Sipcam Oxon S.p.A., Koppert Biological Systems, BioAtlantis Ltd., Acadian Seaplants Limited, Seipasa S.A., Marrone Bio Innovations, Hello Nature International, Tradecorp International, Lallemand Plant Care, Gowan Group, Novozymes.

Asia-Pacific was the largest region in the biostimulants market in 2025. North America was the second-largest region in the global biostimulants market. The regions covered in the biostimulants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biostimulants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biostimulants market consists of the sales of plant extract, inorganic compound, chitosan and other biopolymer, and beneficial microbe biostimulants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.